AKBA
Akebia Therapeutics Inc.
$2.12
-$0.09(-4.07%)
35
Overall
20
Value
45
Tech
42
Quality
Market Cap
$819.30M
Volume
4.23M
52W Range
$1.52 - $4.08
Target Price
$5.80
Key Metrics Overview
| Market Cap | $819.30M | P/E Ratio | 42.40 |
| 52W High | $4.08 | 52W Low | $1.52 |
| Div Yield | N/A | Payout Ratio | 0.0% |
| EPS Growth 3Y | 42.1% | 52W Position | 23.4% |
| Overall Score | 35 | Value Score | 20 |
| Quality Score | 42 | Technical Score | 45 |
Growth Analysis
| EPS Current Est | $0.05 | EPS Next Est | $0.31 |
| EPS Growth Est | +520.0% | DPS Growth 3Y | N/A |
Revenue (5Y)
EBITDA (5Y)
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | AKBA | $2.12 | -4.1% | 4.23M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get Akebia Therapeutics Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW